The Molecular Pathology of Pancreatic Cancer

  • N. R. Lemoine
Conference paper


Our increased understanding of the molecular biology of oncogenes has allowed us to investigate the molecular events associated with pancreatic tumorigenesis. We are beginning to identify those oncogenic events that are necessary and sufficient to produce neoplasia and to determine their temporal sequence of activation. We can now reconstruct many of these events in vitro using gene transfer techniques to introduce activated cellular oncogenes into normal pancreatic epithelium in culture. These are exciting developments because we have the technology to detect oncogene activation for a molecular diagnosis of pancreatic cancer, and we have identified new targets for the design of therapeutic strategies.


Pancreatic Cancer Chronic Pancreatitis Pancreatic Adenocarcinoma Human Pancreatic Cancer Cellular Oncogene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barton CM, Hall PA, Hughes CM et al. (1991) Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 163: 111–116PubMedCrossRefGoogle Scholar
  2. 2.
    Barton CM, Staddon SL, Hughes CM et al. (1991) Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 64:1076–1082PubMedCrossRefGoogle Scholar
  3. 3.
    Bergering BMT, Medema RH, Maassen JA et al. (1991) Insulin stimulation of gene expression mediated by p21ras expression. EMBO J 10:1103–1109Google Scholar
  4. 4.
    Fearon ER, Cho KR, Nigro JM et al. (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49–56PubMedCrossRefGoogle Scholar
  5. 5.
    Kinzler KW, Nilbert MC, Vogelstein B et al. (1991) Identification of a gene located on chromosome 5q21 that is mutated in colorectal cancers. Science 251:1366–1370PubMedCrossRefGoogle Scholar
  6. 6.
    Lemoine NR, Hall PA (1990) Growth factors and oncogenes in pancreatic cancer. Baillieres Clin Gastroenterol 4:815–832PubMedCrossRefGoogle Scholar
  7. 7.
    Lemoine NR, Leung HT, Gullick WJ (1992) Growth factors and the gastrointestinal tract. Gut (in press)Google Scholar
  8. 8.
    Lemoine NR, Jain S, Hughes CM et al. (1991) Ki-ras activation in preinvasive pancreatic cancer. Gastroenterology 102:230–236Google Scholar
  9. 9.
    Lupu R, Colomer R, Zugmaier G et al. (1990) Direct interaction of a ligand for the c-erbB-2 oncogene product with the EGF receptor and pl85neu. Science 249:1552–1555PubMedCrossRefGoogle Scholar
  10. 10.
    Sandgren EP, Quaife CJ, Paulovitch AG, Palmiter RD, Brinster RL (1991) Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA 88:93–97PubMedCrossRefGoogle Scholar
  11. 11.
    Yarden Y, Peles E (1991) Biochemical analysis of the ligand for the neu oncogenic receptor. Biochemistry 30:3543–3550PubMedCrossRefGoogle Scholar
  12. 12.
    Yarden Y, Weinberg RA (1989) Experimental approaches to hypothetical hormones: detection of a candidate ligand of theneu protooncogene. Proc Natl Acad Sci USA 86:3179–3183PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • N. R. Lemoine
    • 1
  1. 1.ICRF Oncology GroupRPMS, Hammersmith HospitalLondonUK

Personalised recommendations